Improvement Image Quality for SuperSonic® MACH Ultrasound System
NCT ID: NCT06360926
Last Updated: 2025-07-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
55 participants
INTERVENTIONAL
2024-07-15
2025-05-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Development of Quantitative Ultrasound Imaging Software Platform
NCT05836246
Effectiveness of Ultra-low-dose Chest CT With AI Based Denoising Solution
NCT05398887
Lung Ultrasound in Comparison With C.T in Covid-19
NCT05158803
Artificial Intelligence-aimed Point-of-care Ultrasound Image Interpretation System
NCT04876157
Prospective Multicenter Study on Clinical Application of Sonazoid in Breast Tumor
NCT04657328
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SuperSonic® Ultrasound System equipped with new software iterations used with a new probe
SuperSonic® Ultrasound System
SuperSonic® Ultrasound System equipped with new software iterations used with a new probe and CE marked probes. The new software and probe are the new study investigational device not CE marked
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SuperSonic® Ultrasound System
SuperSonic® Ultrasound System equipped with new software iterations used with a new probe and CE marked probes. The new software and probe are the new study investigational device not CE marked
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is a minor \< 18 years old and the legal representative has signed the informed consent form.
* Subject is scheduled for at least one or more routine ultrasounds.
* Subject is affiliated to National Social Insurance or a Health Insurance Regimen.
Exclusion Criteria
* Subject or his/her legal representative if a minor is unable to express or understand informed consent.
* Subject is under legal protection
* Subject is deprived of liberty by judicial or administrative decision
* Subject undergoes psychiatric treatment under constraint
* Subject is admitted to a health or social establishment for purposes other than research
* Subject has latex allergy.
* Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SuperSonic Imagine
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Necker-Enfants malades
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024-A00526-41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.